Upexi receives Nasdaq delisting notice over unapproved convertible notes; joins Russell Microcap Index

UPEXI, INC.

Nasdaq says Upexi violated shareholder approval rule by issuing $151M convertible note (July 2025) and $36M note (Jan 2026) without vote.
Notes convertible at $4.25 and $2.39 per share, above market price; combined convertible into ≥20% of pre-transaction shares.
Upexi has 45 days (by Aug 10, 2026) to submit compliance plan; extension of up to 180 days possible if plan accepted.
Added to Russell Microcap Index effective June 29, 2026; CEO says Solana treasury exceeds 2 million SOL.
No immediate delisting; company reviewing options to regain compliance.

Featured in Daily 8-K Digest

Selected #5 for 2026-06-26. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.